‘Noninvasive Blood Glucose Monitors’
Why diabetes patients should research carefully before buying.
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
Solitaire Clash
Can you really make bank playing solitaire on your phone?
TideWe
Don’t get lost in this outdoor company’s dubious origin story.
Homeaglow’s $19 house cleaning service traps customers in hard-to-cancel subscriptions, watchdog group says
Stephanie Zimmermann, Chicago Sun Times
RushMyPassport
Does this passport service live up to its name?